These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 8665374

  • 1. Lipid peroxidation, antioxidant defences and red-cell membrane changes in relation to coronary risk index and symptomatic coronary heart disease.
    Shanmugasundaram KR, Srinivas K, Sundaram P, Sathyaraj D, Muthu R, Padma P, Maheswari RU, Veeraraghavan V, Sharada V, Amudha B.
    J Cardiovasc Risk; 1995 Dec; 2(6):551-61. PubMed ID: 8665374
    [Abstract] [Full Text] [Related]

  • 2. Lipid peroxidative damage in the erythrocytes and elevation of serum LDL-cholesterol, apolipoprotein-B, ferritin and uric acid with age and in coronary heart disease patients.
    El-Gebali HH, Tahir SA, Haider SS, El-Fakhri MM.
    Saudi Med J; 2000 Feb; 21(2):184-9. PubMed ID: 11533779
    [Abstract] [Full Text] [Related]

  • 3. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [Abstract] [Full Text] [Related]

  • 4. [Pathogenetic significance of cholesterol-containing immune complexes and lipid peroxidation in ischemic heart disease].
    Urazgil'deeva SA, Shatalina LV, Gurevich VS.
    Ter Arkh; 1999 Feb; 71(12):8-10. PubMed ID: 10647190
    [Abstract] [Full Text] [Related]

  • 5. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group.
    MacLean DR, Petrasovits A, Connelly PW, Joffres M, O'Connor B, Little JA.
    Can J Cardiol; 1999 Apr; 15(4):434-44. PubMed ID: 10322253
    [Abstract] [Full Text] [Related]

  • 6. Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes.
    Akanji AO, Suresh CG, Al-Radwan R, Fatania HR.
    Metab Syndr Relat Disord; 2009 Dec; 7(6):563-9. PubMed ID: 19642911
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fibrinogen and other coronary risk factors.
    Von Eyben FE, Mouritsen EA, Holm J, Montvilas P, Dimcevski G, Rasmussen IH, Kristensen LL, Suciu G, Von Eyben R.
    Metabolism; 2005 Feb; 54(2):165-70. PubMed ID: 15690309
    [Abstract] [Full Text] [Related]

  • 9. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
    Koter M, Broncel M, Chojnowska-Jezierska J, Klikczynska K, Franiak I.
    Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
    [Abstract] [Full Text] [Related]

  • 10. Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group.
    Connelly PW, MacLean DR, Horlick L, O'Connor B, Petrasovits A, Little JA.
    CMAJ; 1992 Jun 01; 146(11):1977-87. PubMed ID: 1596847
    [Abstract] [Full Text] [Related]

  • 11. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, Garg N, Sinha N.
    Indian Heart J; 2003 Jun 01; 55(3):234-40. PubMed ID: 14560932
    [Abstract] [Full Text] [Related]

  • 12. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.
    Real JT, Chaves FJ, Martínez-Usó I, García-García AB, Ascaso JF, Carmena R.
    Eur Heart J; 2001 Mar 01; 22(6):465-71. PubMed ID: 11237541
    [Abstract] [Full Text] [Related]

  • 13. Association between cholesteryl ester transfer protein gene polymorphisms and variations in lipid levels in patients with coronary heart disease.
    Zheng KQ, Zhang SZ, He Y, Zhang L, Zhang KL, Huang DJ, Sun Y.
    Chin Med J (Engl); 2004 Sep 01; 117(9):1288-92. PubMed ID: 15377415
    [Abstract] [Full Text] [Related]

  • 14. Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease.
    Kesavulu MM, Rao BK, Giri R, Vijaya J, Subramanyam G, Apparao C.
    Diabetes Res Clin Pract; 2001 Jul 01; 53(1):33-9. PubMed ID: 11378211
    [Abstract] [Full Text] [Related]

  • 15. Diet and waist-to-hip ratio: important predictors of lipoprotein levels in sedentary and active young men with no evidence of cardiovascular disease.
    Mansfield E, McPherson R, Koski KG.
    J Am Diet Assoc; 1999 Nov 01; 99(11):1373-9. PubMed ID: 10570674
    [Abstract] [Full Text] [Related]

  • 16. Lipoprotein(a) and coronary heart disease in Indian population.
    Singh S, Dwivedi S, Melkani GC, Rani C, Gaur SP, Mandal SK, Mahua J.
    J Assoc Physicians India; 1999 Dec 01; 47(12):1157-60. PubMed ID: 11225215
    [Abstract] [Full Text] [Related]

  • 17. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S.
    Am J Cardiol; 2009 Jan 01; 103(1):41-5. PubMed ID: 19101227
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Carbohydrate intake is correlated with biomarkers for coronary heart disease in a population of overweight premenopausal women.
    Lofgren IE, Herron KL, West KL, Zern TL, Patalay M, Koo SI, Fernandez ML.
    J Nutr Biochem; 2005 Apr 01; 16(4):245-50. PubMed ID: 15808329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.